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Introduction 
Toxaphene, a suspected carcinogen1 is a broad spectrum chlorinated pesticide consisting of a 
complex mixture of chlorinated bornanes (CHBs)2 which has been produced in comparable 
amounts to PCBs3. The objective of this study was to provide information on the toxicological 
risks posed by toxaphene to the consumer of fish from European waters. The levels of 3 toxaphene 
congeners in various fish species from different geographical locations were determined. These 
data were then used to provide information on the exposure of toxaphene to the consumer of fish.  
 
Methods and Materials 
221 samples were collected, covering 23 different species, from European waters (Fig.1).  Where 
possible, samples were collected in accordance with the JAMP Guidelines4.  Each laboratory used 
their own analysis method, 3 used GC-ECD and 1 GC/NCI-MS.  CPSIL 8 and 19 columns were 
used in all cases. Tissue extraction techniques used were Soxhlet and blender solvent extraction. 
Clean-up methods included GPC, HPLC, sulphuric acid and alumina.  All laboratories used silica 
gel for the separation of the different groups of chlorinated compounds.  The comparability of 
these methods was assessed through a series of intercomparison exercises.  In addition, herring oil 
was analysed as a reference material with each batch of samples to assess the within and between 
laboratory variation. Based on the results of these studies CHBs 26, 50 and 62 were selected for 
analyses.  In order to maximise the information obtained from the baseline survey 3 sampling 
strategies were incorporated into the survey with a view to measuring the: 
1. variation in toxaphene concentration in tissues of similar individuals of the same species. 
2. geographical distribution of toxaphene in marine fish species expressed on a lipid basis. 
3. human exposure to toxaphene from fish consumption.  
 
Results and discussion 
Variation study on individual fish: Table 1 shows the summarised results of the variation study. 
The ranges and median for Barents Sea golden redfish are higher that the other three groups.  An 
ANOVA shows no significant difference (p>0.05) in the concentration of the Σ3CHBs in the lipids 
of cod liver, herring and mackerel, but the concentration in the golden redfish is significantly 
higher than the other three species. The Σ3CHBs measured in the variation study suggested higher 
levels, on a lipid basis, in fish from the Barents Sea than from the other three regions. The relative 
contribution of individual CHB congeners to the Σ3CHB congeners varied considerably within 3 
of the groups but not in the golden red fish from the Barents Sea. It is unclear if this is due to 
analytical uncertainties or is a true reflection of the variances within the populations. 
 
Table 1: The mean, coefficient of variation (CV), range and interquartile range (of the sum of 
CHB26+50+62) in µgkg-1 lipid weight, length (mm) and % total lipid. 
 Mean CV Range Interquarile  
Mackerel (n=24)  Atlantic west of Ireland – Region D 
Σ3CHBs 19.4 52.6 5.7 -40.2 11.1 - 24.4 
Length 255 14.3 210 – 310 219- 290 
Lipids 9.5 63.2 2.2- 22.5 4.6 - 15.3 
Golden redfish  (n=24)  - Barents Sea – Region B 
Σ3CHBs 76.2 40.3 37.0 – 181.0 58.0 - 85.2 
Length 288.5 9.6 230 – 350 280 – 310 
Lipids 2.8 42.7 1.3 – 6.2 1.7 –3.6 
Cod liver (n=25)  – North Sea – Region E 
Σ3CHBs 20.2 44.2 12.7 - 45.48 16.1 – 28.5 
Length 420.8 6.2 380 – 490 400 – 430 
Lipids 50.5 21.2 28.3 – 70.7 42.6 - 54.2 
Herring (n=26)  – Baltic Sea – Region F 
Σ3CHBs 22.3 76.9 8.0 – 88.0 11.5 – 23.7 
Length 234.6 5.4 220 – 260 222 – 240 
Lipids 5.7 57.7 1.0 – 16.0 4.0 – 6.7 
 
Geographical distribution: To investigate the geographical distribution of toxaphene in marine 
fish species, expressed on a lipid basis, the survey area was divided into 6 regions A to F (Fig. 1).  
Region A was not included in the comparative statistical analysis as no data for CHB26 were 
available for this region.  The box and whisker plot (Fig. 2) shows the concentration ranges of the 
Σ3CHBs  (Σ2CHBs for region A) in biota from the different regions. No significant difference 
(p>0.05) in the concentrations of the Σ3CHB congeners in the lipids of fish and shellfish from the 
Barents Sea (region B) and Norwegian Sea (region C) was detected. Both these areas, however, 
show significantly higher levels (p<0.05) than observed in the Baltic Sea (region F), North Sea 
(region E) and Irish coastal waters (region D). These data suggest that fish from the Barents and 
Norwegian Seas have elevated concentrations compared to the other 3 regions. In all regions the 
highest concentrations of Σ3CHB are generally measured in lipid rich species.  
 
Human Exposure: Human exposure to toxaphene occurs mainly through the consumption of 
contaminated fish5.  In this study, fish with a low lipid content contained levels for the Σ3CHBs of 
0.04-0.52, 0.01-0.90 and 0.02- 0.07 µgkg-1 for cod, plaice and haddock, respectively. In lipid rich 
fish the ranges were 0.76-14.4, 13.5-18.4 and 0.11-5.90 µgkg-1 for herring, Greenland halibut and 
mackerel respectively.  In farmed salmon and trout the range was 1.83-12.4 µgkg-1 wet weight.   In 
general the concentrations in the baseline survey data set are lower than previously reported5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The locations where samples were collected, the division of the study area into 
geographical regions A to F.  The ♦ denotes the location where the samples for the variation study 
were collected. 
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Figure 2: Box and whisker plot of the concentration, on a lipid basis, of the Σ3CHBs 26, 50 and 
62 (Σ2CHBs, 26 and 50 for region A) in various fish species.  
 
Tolerable Daily Intakes (TDI) are generally based on total toxaphene.  To convert the Σ3CHBs to 
total toxaphene conversion factors, based on the simultaneous analyses Σ3CHBs and total 
toxaphene for 55 samples, were estimated. Conversion factors for marine fish, eel and mussel were 
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estimated as 12.4, 41.6, and 24.0, respectively. Using these factors the daily intake of total 
toxaphene, through the consumption of fish, was estimated.  Fish consumption for Germany is 12 
kg/person/year, for Ireland, Norway and The Netherlands it is 18, 46 and 12 kg/person/year, 
respectively6.  Fig.3 shows the estimated  daily intake of toxaphene, assuming single species 
consumption. For an average fish consumer with a body weight of 60 kg the estimated average 
daily intake of toxaphene for Norway was 1.2 µg, and 0.4, 0.5, and 0.2 µg for consumers of 
Germany, Ireland, and The Netherlands respectively. 
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Figure 3: The estimated daily intake of total toxaphene (µg) from the consumption of various fish 
species in Germany, Ireland, Norway and The Netherlands. Solid lines indicate average daily 
intakes in each country. TDI levels from Canada (12 µg) and the U.S. for chronic toxicity (15 µg) 
are also shown. 
Only the toxaphene intake from the consumption of 46 kg per year of Greenland halibut would 
exceed the Canadian TDI of 12 µg per day for a person of 60 kg. Based on the information 
obtained in this study it can be concluded that no adverse toxicological effects from the exposure 
to toxaphene, through the consumption of fish from European waters, are expected.  
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